Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.27
+0.61 (9.16%)
At close: Jun 9, 2026, 4:00 PM EDT
7.26
-0.01 (-0.14%)
After-hours: Jun 9, 2026, 7:42 PM EDT
Unicycive Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
194.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 675.00K | -276.00K | -29.02% |
| Dec 31, 2022 | 951.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Q32 Bio | 53.74M |
| Alector | 18.42M |
| Tonix Pharmaceuticals Holding | 17.56M |
| MediWound | 14.48M |
| Caribou Biosciences | 11.20M |
| Equillium | 4.39M |
| Cartesian Therapeutics | 1.78M |
UNCY News
- 4 days ago - Unicycive Therapeutics files $150M mixed securities shelf - TheFly
- 4 days ago - Unicycive Therapeutics Registration statement: Registration filing - Filings
- 7 days ago - Unicycive Therapeutics price target raised to $18 from $15 at Benchmark - TheFly
- 8 days ago - Unicycive Therapeutics Earnings release - Filings
- 8 days ago - Unicycive Therapeutics Earnings release - Filings
- 8 days ago - Unicycive Therapeutics Earnings release - Filings
- 8 days ago - Unicycive Therapeutics Earnings release - Filings
- 8 days ago - Unicycive Therapeutics Earnings release - Filings